Masterwort (Peucedanum ostruthium): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Masterwort work as a digestive remedy?

Masterwort contains bitter compounds and furanocoumarins that stimulate digestive secretions. The bitter principles trigger the vagus nerve reflex, increasing gastric acid, bile, and pancreatic enzyme production. Imperatorin and ostruthin contribute to antispasmodic effects on smooth muscle in the digestive tract. These mechanisms support its traditional use as a digestive bitter. Evidence Level C is based on pharmacological studies and traditional use rather than clinical trials.

Can Masterwort interact with blood thinners or anticoagulant medications?

Yes, Masterwort poses significant interaction risks with anticoagulant medications. The furanocoumarin compounds, including imperatorin, possess blood-thinning properties that may potentiate the effects of warfarin, heparin, and antiplatelet drugs like aspirin, increasing bleeding risk. Additionally, furanocoumarins can inhibit cytochrome P450 enzymes, potentially altering metabolism of various pharmaceuticals. Patients on anticoagulants should avoid Masterwort entirely. Evidence Level C.

What is the recommended dosage for Masterwort root?

Traditional adult dosages include 1-3 grams of dried root prepared as a tea, or approximately 2ml of tincture taken daily. The dried root is typically decocted for 10-15 minutes to extract active compounds. Due to limited modern clinical data and potential phototoxicity, start with lower doses and do not exceed recommended amounts. Evidence Level C based on traditional use and pharmacopoeial standards.

Is Masterwort safe to take during pregnancy and breastfeeding?

No, Masterwort is contraindicated during pregnancy and breastfeeding. The furanocoumarin content poses risks of uterine stimulation and potential fetal harm. These compounds can pass into breast milk and may cause photosensitivity reactions in nursing infants. Additionally, the blood-thinning effects present additional pregnancy risks. Women who are pregnant, planning pregnancy, or breastfeeding should avoid all Masterwort preparations. Evidence Level C.

What are the side effects of taking Masterwort?

Masterwort can cause phototoxic skin reactions due to furanocoumarins, resulting in severe sunburn-like symptoms, blistering, and skin discoloration when exposed to sunlight or UV light. Gastrointestinal upset, including nausea and diarrhea, may occur at higher doses. Blood-thinning effects can increase bruising and bleeding tendency. Discontinue use immediately if skin sensitivity develops and avoid sun exposure for 24-48 hours after ingestion. Evidence Level C.

What was Masterwort used for in traditional Alpine medicine?

Masterwort was revered as a panacea in medieval European and Alpine traditional medicine, earning the name 'Imperial Herb.' It was used as a general tonic, digestive bitter to stimulate appetite and relieve indigestion, diaphoretic to promote sweating during fevers, and remedy for infections. The root was traditionally prepared as a decoction or tincture. These historical applications are supported by Evidence Level C based on ethnobotanical records and traditional use.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 27 PubMed articles · model: gemma4:31b

Summary

Masterwort (Peucedanum ostruthium) is a perennial herb native to alpine regions of Europe, traditionally used for gastrointestinal and respiratory disorders [PMID: 32354017, 26493217].

Background

Peucedanum ostruthium (also known as Imperatoria ostruthium) is an Apiaceae species native to the mountains of central and southern Europe [PMID: 35807516, 36616243]. It is cultivated as an ornamental plant and used in the production of spirits and bitters [PMID: 26493217, 21425828].

Traditional uses

Traditionally used in the Alpine region of Austria and Italy to treat disorders of the gastrointestinal and respiratory tract [PMID: 32354017, 30342388]. In Sweden, it was used as an ethnoveterinary remedy for horses and cattle from the 17th to 19th centuries, as well as in some human remedies [PMID: 36616243].

Active compounds

The plant contains coumarins including osthole, ostruthin, imperatorin, isoimperatorin, oxypeucedanin, and oxypeucedanin hydrate [PMID: 21425828, 28513464]. Other identified compounds include phthalides (cnidilide, Z-ligustilide, senkyunolide) [PMID: 17340269] and essential oil components such as sabinene, 4-terpineol (rhizome), beta-caryophyllene, and alpha-humulene (herb) [PMID: 11837677, 40648055].

Mechanism of action

Extracts from roots and rhizomes inhibit the expression of inflammatory markers E-selectin and VCAM-1 by interfering with NF-κB signaling, specifically affecting IκBα phosphorylation, degradation, and resynthesis, as well as the nuclear translocation of RelA [PMID: 32825714]. Some compounds act as dual inhibitors of cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) [PMID: 9690339, 35807516]. Osthole may modulate the PI3K/Akt/mTOR signaling pathway [PMID: 30922159].

Clinical evidence

Evidence DInflammation/Pyrexia

Oral administration of 10% ethanolic root extract inhibited carrageenan-induced rat paw edema and showed antipyretic effects in rats [PMID: 9690339]

Evidence DWound Healing

Leaf extracts showed strong induction of wound closure in in vitro scratch tests on HaCaT keratinocytes [PMID: 35807516]. A topical ointment containing leaf extract and propolis showed improvement in rat skin ulcers compared to untreated lesions [PMID: 29877862]

Evidence DBacterial Infections

Ostruthin demonstrated in vitro activity against rapidly growing Mycobacteria (e.g., M. smegmatis, M. abscessus) [PMID: 12709907, 34572657] and anti-staphylococcal activity against S. aureus [PMID: 37636068].

Evidence DVascular Smooth Muscle Proliferation

Ostruthin was identified as the major substance inhibiting serum-induced proliferation of rat aortic vascular smooth muscle cells [PMID: 21627108]

Safety & adverse effects

In vitro MTT assays on HaCaT keratinocytes and L929 fibroblasts showed low cytotoxicity of leaf and rhizome extracts [PMID: 35807516].

Evidence summary

The current evidence is primarily based on in vitro studies, animal models, and phytochemical analyses (Level D). There are no human clinical trials provided in the source material.

PubMed sources

1.PMID: 12506234 (2003) — 8-(2-bromo-3-methoxy-3-methylbutyl)-7-methoxycoumarin. · Acta crystallographica. Section C, Crystal structure communications
2.PMID: 28513464 (2017) — Pharmacological features of osthole. · Postepy higieny i medycyny doswiadczalnej (Online)
3.PMID: 32825714 (2020) — Peucedanum ostruthium Inhibits E-Selectin and VCAM-1 Expression in Endothelial Cells through Interference with NF-κB Signaling. · Biomolecules
4.PMID: 34572657 (2021) — Efflux Pump Inhibition and Resistance Modulation in Mycobacterium smegmatis by Peucedanum ostruthium and Its Coumarins. · Antibiotics (Basel, Switzerland)
5.PMID: 26493217 (2015) — DNA-based identification of Peucedanum ostruthium specimens and detection of common adulterants by high-resolution melting curve analysis.

Masterwort

Sources & Citations

Calculate a safe dose of Masterwort